Aligos Therapeutics Inc
Aligos Therapeutics Inc logo
ALGS

Aligos Therapeutics Inc (ALGS)

$1.518.63%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.43
Day's Range
$1.54
$1.03
52-Week Range
$17.97
1 month return9.49%
3 month return29.31%
1 year return90.46%
5 year return89.9%

Company Information

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its team has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
OrganizationAligos Therapeutics Inc
Employees80
CEODr. Lawrence M. Blatt MBA, Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 11 analysts ratings

Buy
54%
Buy
45%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for Aligos Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 633.33%

Current

$1.5

Target

$11.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
6
6
7
Hold
5
5
4
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
53.8M
Book Value
4.33
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-3.22
Wall Street Target Price
6.13

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
12.34
Price/Book (mrq)
0.32
Enterprise Value
-116507213
Enterprise Value/Revenue
69.48
Enterprise Value/Ebitda
0.94

Technicals

50 Day MA
2.18
200 Day MA
10.21

Institutional Holdings

EcoR1 Capital, LLC

9.25%

Vivo Capital, LLC

8.31%

Hillhouse Capital Advisors, Ltd.

5.54%

Versant Venture Management LLC

5.43%

Baker Bros Advisors LP

4.86%

Novo A/S

4.57%

Discover more

Frequently Asked Questions

What is Aligos Therapeutics Inc share price today?

Can Indians buy Aligos Therapeutics Inc shares?

How can I buy Aligos Therapeutics Inc shares from India?

Can Fractional shares of Aligos Therapeutics Inc be purchased?

What are the documents required to start investing in Aligos Therapeutics Inc stocks?

What are today’s High and Low prices of Aligos Therapeutics Inc?

What are today’s traded volumes of Aligos Therapeutics Inc?

What is today’s market capitalisation of Aligos Therapeutics Inc?

What is the 52 Week High and Low Range of Aligos Therapeutics Inc?

How much percentage Aligos Therapeutics Inc is down from its 52 Week High?

How much percentage Aligos Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Aligos Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Aligos Therapeutics Inc?